Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Ronovo Closes Series A to Develop Surgical Robotics Devices for China

publication date: Apr 23, 2021

Ronovo Surgical, a Shanghai company developing novel minimally invasive and digital surgery devices, announced it has completed a Series A financing. Ronovo was founded in 2019 by surgeons, medtech veterans and robotics experts to bring the latest surgical technologies to China's market. The company has established a soft tissue surgical robotics R&D  program and will also license technology from other surgical device companies. The Series A round was co-led by Matrix Partners China and Vivo Capital, with support from seed investor Lilly Asia Ventures and participation from GGV Capital. More details....

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
The Ritz-Carlton Shanghai Pudong
March 23-25, 2021